Updated:
Upcoming Laboratorio Reig Jofre dividendDividends from Laboratorio Reig Jofre for 2026 have not been sketched out.
The dividend issued by Laboratorio Reig Jofre on June 8, 2026 amounted to 0.024 euros.
Reig Jofre rewards its associates according to the conditions approved by the General Shareholders' Meeting, offering two possibilities, one of which is the flexible dividend or "scrip dividend", which allows investors the possibility of receiving bonus shares in the company.
Another option is to receive the interest payment in cash, which is made annually in a single installment, at a fixed price, usually between the months of May and September, with a dividend yield of 1.60% and a payout of approximately 38%.
Join +33,000 investors who get notifications, analysis and news.
Dividend calendar of Laboratorio Reig Jofre
There is no Dividend Calendar of Laboratorio Reig Jofre defined for 2026.
Dividend history of Laboratorio Reig Jofre
In this table you can see the complete history:
| Year | Ex-Dividend | Amount | Total |
|---|---|---|---|
| 2026 |
05/21/2026 |
0.024 € |
0.024 € |
| 2025 |
05/15/2025 |
0.049 € |
0.049 € |
| 2024 |
05/17/2024 |
0.04 € |
0.04 € |
| 2023 |
05/05/2023 |
0.04 € |
0.04 € |
| 2022 |
06/15/2022 |
0.04 € |
0.04 € |
| 2021 |
06/10/2021 |
0.045 € |
0.045 € |
| 2020 |
09/16/2020 |
0.039 € |
0.039 € |
| 2019 |
05/07/2019 |
0.045 € |
0.045 € |
| 2018 |
06/15/2018 |
0.046 € |
0.046 € |
| 2013 |
06/06/2013 |
0.74 € |
0.74 € |
Information about Laboratorio Reig Jofre
Reig Jofre, is a company dedicated to the pharmaceutical industry specialized in the research, development, manufacture and marketing of medicines and food supplements.
It was founded in 1929 in Barcelona and currently has four production and development centers in Europe, although its products are available in more than 70 countries, with its own subsidiaries in 8 of them, France, Portugal, Belgium, United Kingdom, Poland, Sweden, Singapore and Spain, supported by more than 130 commercial partners.
Its activity is structured in three business units, "Pharmaceutical Technologies", a unit dedicated to injectable drugs and antibiotics, "Specialty Pharmacare", specialized in dermatology, women's health and osteoarticular health, and "Consumer Healthcare", dedicated to the manufacture of food supplements, topical disinfectants and alcohols.
Frequently asked questions about Laboratorio Reig Jofre dividends
Laboratorio Reig Jofre pays dividends on a Annual basis.
Laboratorio Reig Jofre has the Ticker or stock code RJF.
The CEO of Laboratorio Reig Jofre in 2026 is Mr. Ignasi Biosca Reig.
The ISIN of Laboratorio Reig Jofre is ES0165359029.
Laboratorio Reig Jofre does not have a growing dividend program. Dividends have not shown a steady growth in the last 5 years.
Check the latest comments and participate in the live chat on Laboratorio Reig Jofre stocks (RJF).
No comments yet. Be the first to join in.
